BCL2 and acute myeloid leukemia: METLL3 activity promotes tumorigenesis in AML by enhancing BCL2 and PTEN translation50, whereas in glioblastoma stem cells, it suppresses growth and self‐renewal by reducing expression of ADAM1945.